Articles

Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia

Hannover Medical School, Hannover, Germany;
Hannover Medical School, Hannover, Germany;
Hannover Medical School, Hannover, Germany;
Hannover Medical School, Hannover, Germany;
Hannover Medical School, Hannover, Germany;
Bayer AG, Berlin, Germany;
Hannover Medical School, Hannover, Germany;
Hannover Medical School, Hannover, Germany;
Hannover Medical School, Hannover, Germany;
School of Medicine & University Hospital Bonn;
Bayer AG, Berlin, Germany;
Bayer AG, Berlin, Germany;
Helmholtz Centre for Infection Research, Braunschweig, Germany;
Hannover Medical School, Hannover, Germany;
Hannover Medical School, Hannover, German;
Bayer AG, Whippany, NJ, USA
Bayer AG, Berlin, Germany;
Hannover Medical School, Hannover, Germany;
Haematologica Early view Apr 2, 2020 https://doi.org/10.3324/haematol.2019.236992